JW THERIAC Trademark

Trademark Overview

On Tuesday, December 3, 2013, a trademark application was filed for JW THERIAC with the United States Patent and Trademark Office. The USPTO has given the JW THERIAC trademark a serial number of 86133265. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Monday, April 18, 2022. This trademark is owned by JW Holdings Corporation. The JW THERIAC trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:

Business and management consulting services in the field of genetics, bioengineering, microbiology, chemistry and pharmaceuticals; business consulting and business information for enterprises; business consulting and information services

Research and development of pharmaceuticals for the treatment of cancer; pharmaceutical products development; pharmaceutical research and development; consulting services in the fields of pharmaceutical research and development; pharmaceutical product evaluation; consultancy pertaining to pharmacology; research and development in the field of medical products and pharmaceuticals; medical research
jw theriac

General Information

Serial Number86133265
Word MarkJW THERIAC
Filing DateTuesday, December 3, 2013
Status701 - SECTION 8 - ACCEPTED
Status DateMonday, April 18, 2022
Registration Number4846637
Registration DateTuesday, November 3, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 18, 2014

Trademark Statements

Goods and ServicesBusiness and management consulting services in the field of genetics, bioengineering, microbiology, chemistry and pharmaceuticals; business consulting and business information for enterprises; business consulting and information services
NOT AVAILABLE"THERIAC"
Goods and ServicesResearch and development of pharmaceuticals for the treatment of cancer; pharmaceutical products development; pharmaceutical research and development; consulting services in the fields of pharmaceutical research and development; pharmaceutical product evaluation; consultancy pertaining to pharmacology; research and development in the field of medical products and pharmaceuticals; medical research

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, December 19, 2013
Primary Code035
First Use Anywhere DateWednesday, September 18, 2013
First Use In Commerce DateWednesday, September 18, 2013
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, December 19, 2013
Primary Code042
First Use Anywhere DateWednesday, September 18, 2013
First Use In Commerce DateWednesday, September 18, 2013

Trademark Owner History

Party NameJW Holdings Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSEOUL 137-864
KR
Party NameJW Holdings Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSEOUL 137-864
KR
Party NameJW Holdings Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSEOUL 137-864
KR

Trademark Events

Event DateEvent Description
Friday, December 6, 2013NEW APPLICATION ENTERED
Saturday, May 31, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 19, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 15, 2014ASSIGNED TO EXAMINER
Friday, March 21, 2014NON-FINAL ACTION WRITTEN
Friday, March 21, 2014NON-FINAL ACTION E-MAILED
Friday, March 21, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 16, 2014ASSIGNED TO LIE
Saturday, May 31, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, May 31, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 16, 2014FINAL REFUSAL WRITTEN
Wednesday, July 16, 2014FINAL REFUSAL E-MAILED
Wednesday, July 16, 2014NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, September 1, 2014TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, September 1, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 2, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 29, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 18, 2014PUBLISHED FOR OPPOSITION
Thursday, July 9, 2015TEAS STATEMENT OF USE RECEIVED
Tuesday, August 4, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 27, 2015SU - NON-FINAL ACTION - WRITTEN
Thursday, October 16, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 29, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 18, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 13, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, July 9, 2015USE AMENDMENT FILED
Tuesday, August 4, 2015STATEMENT OF USE PROCESSING COMPLETE
Thursday, August 27, 2015NON-FINAL ACTION E-MAILED
Thursday, August 27, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, September 26, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 3, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, November 3, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, October 26, 2021TEAS SECTION 8 RECEIVED
Tuesday, September 1, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 8, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 8, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 25, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sunday, November 3, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, April 18, 2022NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Monday, April 18, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, April 18, 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED

Related Keywords

theriac development research consulting pharmaceutical business pharmaceuticals services medical information products